...
首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >Ultrastructural changes and activation differences in platelet concentrates stored in plasma and additive solution.
【24h】

Ultrastructural changes and activation differences in platelet concentrates stored in plasma and additive solution.

机译:血浆和添加剂溶液中储存的浓缩血小板的超微结构变化和活化差异。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: The aim of this study was to demonstrate how ultrastructural morphology of platelets stored in different media correlate with the appearance of particular activation markers on their cell surface. STUDY DESIGN AND METHODS: Concentrates of buffy coat-derived platelets were stored in plasma or a glucose-free citrate-acetate-NaCl platelet additive solution (PAS2, Baxter Healthcare Corp.). Activation markers on platelets were measured by flow cytometry and compared with changes in the platelet cell surface as demonstrated by electron microscopy. Levels of the vasoactive cytokines vascular endothelial growth factor (VEGF) and RANTES (regulated upon activation, normal T-cell expressed and secreted) were determined in the storage medium of the platelet concentrate. RESULTS: The activation markers CD62P and CD63 and the binding of thrombospondin measured by flow cytometry were expressed to a higher extent in the PAS2 group compared with the plasma group. The difference reached significance on Day 3 (CD62P: 66.37 +/- 2.44 vs. 37.83 +/- 2.03, p < 0.001; CD63: 42.11 +/- 3.29 vs. 34.84 +/- 2.04, p < 0.05; and thrombospondin binding: 18.84 +/- 3.9 vs. 13.98 +/- 3.87, p < 0.001, respectively). The form factor that is related to changes of the platelet shape was determined by image analysis and correlated significantly with the cell surface expression of CD62P (p < 0.001) and with CD63 (p < 0.05) and with thrombospondin binding (p < 0.05). The chemokines VEGF and RANTES were measured at higher levels in the PAS2 group. CONCLUSIONS: With exception of baseline activation probably due to necessary handling procedures, platelets remain relatively unaltered and more stable in plasma in comparison to storage in PAS2.
机译:背景:这项研究的目的是证明储存在不同培养基中的血小板的超微结构形态与细胞表面特定活化标记物的出现如何相关。研究设计和方法:将浓缩血沉棕黄层的血小板浓缩物储存在血浆或无葡萄糖的柠檬酸盐-乙酸盐-NaCl血小板添加剂溶液(PAS2,Baxter Healthcare Corp.)中。通过流式细胞术测量血小板上的活化标记,并通过电子显微镜与血小板细胞表面的变化进行比较。在血小板浓缩液的储存介质中测定血管活性细胞因子血管内皮生长因子(VEGF)和RANTES的水平(在激活时进行调节,表达和分泌正常的T细胞)。结果:PAS2组与血浆组相比,流式细胞仪检测到的激活标志物CD62P,CD63和血小板反应蛋白的结合程度更高。差异在第3天达到显着性(CD62P:66.37 +/- 2.44 vs. 37.83 +/- 2.03,p <0.001; CD63:42.11 +/- 3.29 vs. 34.84 +/- 2.04,p <0.05;和血小板反应蛋白结合: 18.84 +/- 3.9对13.98 +/- 3.87,p <0.001)。通过图像分析确定与血小板形状变化相关的形状因子,并且与CD62P(p <0.001)和CD63(p <0.05)以及血小板反应蛋白结合(p <0.05)的细胞表面表达显着相关。在PAS2组中,趋化因子VEGF和RANTES的含量较高。结论:基线活化可能是由于必需的处理程序而引起的,与储存在PAS2中相比,血小板在血浆中保持相对不变并且更稳定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号